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Abstract: Diabetes is a chronic disease in which there are high levels of sugar in the blood. Insulin is a hormone
that regulates the blood glucose level in the body. Diabetes mellitus can be caused by too little insulin, a resistance
to insulin, or both. Although research activities on controlling blood glucose have been attempted to lower the blood
glucose level in the quickest possible time, there are some shortages in the amount of the insulin injection. In this
paper, a complete model of the glucose–insulin regulation system, which is a nonlinear delay differential model, is used.
The purpose of this paper is to follow the glucose profiles of a healthy person with minimum infused insulin. To achieve
these purposes, an intelligent fuzzy controller based on a Mamdani-type structure, namely the swarm optimization tuned
Mamdani fuzzy controller, is proposed for type 1 diabetic patients. The proposed fuzzy controller is optimized by a novel
heuristic algorithm, namely linearly decreasing weight particle swarm optimization. To verify the robust performance
of the proposed controller, a group of 4 tests is applied. Insensitivity to multiple meal disturbances, high accuracy, and
superior robustness to model the parameter uncertainties are the key aspects of the proposed method. The simulation
results illustrate the superiority of the proposed controller.
Key words: Diabetes, fuzzy logic control, linearly decreasing weight particle swarm optimization, Wang model

1. Introduction
The World Health Organization (WHO) apprises that over 180 million people in the world have diabetes and
this rate is estimated to reach 360 million people by 2030 [1]. This growth is associated with the increasing
average age of society, an increase in obesity, and also probably the increase in the longevity of those with
diabetes. The difficulties of diabetes mellitus are far less prevalent and less intense in individuals who have
well-controlled blood sugar levels [2,3].
More extensive health difficulties precipitate the detrimental impacts of diabetes. These include smoking, high cholesterol levels, obesity, hypertension, and the absence of orderly exercise. Diabetes mellitus can
lead to some side effects such as blindness, hyperglycemia, hypoglycemia, diabetic coma, and respiratory infections. Blindness is one of the most dangerous complications of diabetes, with a morbidity of 50–65 per 100,000
diabetics per year in Europe [4–6]. However, with good care, visual injuries owing to diabetes can be avoided
for the overwhelming majority of patients.
Medical sciences have placed more emphasis on prevention, and in the case of illness, only offer general
treatment. In recent years, to improve the treatment of diabetes, new instruments have been designed using
biomedical engineering; for instance, the insulin pump. The insulin pump is a medical device used for the
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administration of insulin in the treatment of diabetes mellitus, which is also known as continuous subcutaneous
insulin infusion therapy. The insulin pump has an application in the treatment of both types of diabetes [7–
10], but what is important is the designing of an appropriate controller for the insulin pump. This paper is
associated with expanding an enhanced glucose controller for the insulin pump that is according to an optimal
fuzzy-proportional-integral (PI) controller.
Recently, considerable attempts have been made in the expansion of control methods that were assumed
to be capable of mimicking the β -cell normal capability [11–15]. The majority of them depended on the easy
Bergman’s model, which may lead to inefficient treatment owing to the fact that this model cannot generally
express the oscillatory behavior of the glucose–insulin system. Moreover, despite the good performance of these
controllers, they do not have the capabilities to deal with the uncertainties that exist in biological models.
Furthermore, the classical controllers cannot appropriately counter nonlinear and complex systems. As a result,
if these controllers are used in practice, it is likely that they would fail when being applied to an actual patient.
In recent years, researchers have extensively used fuzzy logic for the modeling, identification, and control
of highly nonlinear dynamic systems [16]. During a set of comparative studies, the advantage of fuzzy controllers
over classical controllers has been proven. The purpose of these studies was to hold the blood glucose level at
a determined reference point, 4.5 mmol/L, by considering Bergman’s minimal model as a model of diabetes
mellitus. In [17], a comparative study between the ordinary PI-derivative (PID) and a fuzzy logic controller
with the assumption of continuous insulin infusion was represented, where both controllers were designed for the
purpose of maintaining the blood glucose level at around 60–100 mg/dL before eating and under 140 mg/dL after
eating. In [18], a fuzzy controller based on the ordinary PID controller was designed. In [19], the excellence of
the fuzzy PI controller over other controllers was shown, where Bergman’s minimal model was used. Aside from
being the fastest at bringing the glucose concentration back to a desired value, it is also capable of eliminating
errors caused by intense initial circumstances and restoring the blood glucose level to its basal amount within a
duration of nearly 1 h. In [20], the efficiency of the fuzzy closed-loop controller was compared with the ordinary
PID controller in the presence of intense initial conditions, including an unusual meal disturbance, variations in
the parameters of the system, and a white noise that indicates a sensor’s error. Although the fuzzy controllers
demonstrated better efficiency than the other methods, they have some shortages. Among their disadvantages
are: 1) their purpose is to preserve the glucose level at a determined reference point rather than mimicking
the glucose–insulin dynamics in healthy individuals, and 2) their significant drawback is the lack of systematic
methods to define the fuzzy rules and fuzzy membership functions. Most fuzzy rules are based on human
knowledge and differ among people, despite the same system performance. On the other hand, it is difficult to
assume that the given expert’s knowledge captured in the form of the fuzzy controller leads to optimal control.
Hence, the effective approaches for tuning the membership function and control rules without a trial and error
method are significantly required.
Motivated by the aforementioned research, the purpose of this paper is to present a novel optimal fuzzy
PI controller for stabilizing the blood glucose concentration of type 1 diabetic patients, where a Mamdanitype of fuzzy controller is designed based on a generalized mathematical nonlinear delay differential model of
glucose–insulin. This model, with scheduled insulin infusion, demonstrates glucose status in healthy people [21].
The optimized controller is also designed in a way that the glucose oscillation under its control mimics that of
the reference model. To achieve this objective, linearly decreasing inertia weight particle swarm optimization
(LDW-PSO), which is an improved algorithm of PSO, is employed to choose the best parameter amounts of
the inputs and the output fuzzy membership functions, as well as the closed-loop weighting factors.
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Recently, the PSO algorithm has been become available and there have been promising techniques
introduced for real-world optimization problems [22]. Compared to the genetic algorithm (GA), PSO takes
less time for each function evaluation as it does not use many of the GA operators like mutation, crossover,
and selection operator [23]. Due to the simple concept, easy implementation, and quick convergence, nowadays
PSO has gained much attention and wide applications in different fields [24]. The rest of this paper is organized
as follows. In the next section, the mathematical model of the glucose insulin regulatory system in a type 1
diabetes mellitus patient is introduced and details of the proposed control are then presented. The simulation
results of the proposed control system with discussions are then presented and, finally, the conclusions are
drawn.
2. Glucose–insulin model
Insulin treatments are frequently presented based on clinical trials; however, mathematical models have been
considered for some special conditions. A delay differential equation model to simulate the pancreatic insulin
secretion with exogenous insulin infusion was proposed by Wang et al. [21]. This model was studied analytically
and numerically. The existence and stability of intermittent solutions was also proven. In addition, the behavior
of the system, under intermittent exogenous glucose infusion and insulin infusion, was studied.
The insulin and the glucose dynamics under insulin treatment from outside the body for a type 1 diabetic
patient are shown as follows [21]:
dG
= Gin (t) − f2 (G(t)) − f3 (G(t))f4 (I(t − τ3 )) + f5 (I(t − τ2 )),
dt

(1)

dI
= Iin (t) − di (I(t)),
dt

(2)

whereG(t) and I(t) represent the plasma glucose and the insulin concentrations at time t ≥ 0, respectively.
And Gin (t) and Iin (t) denote the glucose absorption rate and the exogenous insulin infusion rate, respectively,
as shown in Figures 1 and 2. Finally, di is the clearance rate parameter.
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(3)

(4)

f2 (G(t)) given in Eq. (5) is the insulin-independent exploitation of glucose mostly by brain and nerve cells.
The term f3 (G(t)) f4 (I(t)) demonstrates the insulin-dependent exploitation of the glucose owing to muscle,
fat, and other tissues. The corresponding formulations of these functions are presented in Eqs. (6) and (7),
respectively; g τz > 0 is the time delay for insulin-dependent glucose exploitation by cells and τy > 0 is the
hepatic glucose generation delay. f5 (I(t)) given in Eq. (8) shows the glucose generation function regulated by
the glucose concentration. The insulin decomposition is proportional to the insulin concentration by parameter
di , in which di > 0.
f2 (G(t)) = Ub (1 − exp(−G/(C2 Vg )))
(5)
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f3 (G(t)) =

G
C3 ∗ Vg

(6)

f4 (I(t)) = U0 + (Um − U0 )/(1 + exp(−βln(I/C4 (1/Vi + 1/(0.2ti )))))

(7)

f5 (I(t)) = Rg/(1 + exp(α̂(I/Vp − C5 )))

(8)

In above equations, Ub , C2 , Vg , C3 , U0 , Um , β , C4 , Vi , ti , Rg , α , Vp , and C5 are fixed quantities.
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Figure 1. The glucose absorption rate (mg dL −1 min −1 ) .
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Figure 2. The exogenous insulin infusion rate (mU/min).

3. Dynamic model of the micropump of insulin infusion
The dynamic model of the micropump of insulin infusion was given in [25]. The unloaded volume variation can
be stated as:
3r4 (5 + 2µ)(1 − µ)dU
∆V =
,
(9)
4h2 (3 + 2µ)
where U is the voltage applied to the lead zirconate titanate (PZT) film with piezoelectric factor d. The
thickness of the film is hµ m and the radius is rµ m. µ is the Poisson ratio. Note that the volume variation is
in proportion to the voltage variation applied to the PZT film. This proportion can be written as follows:
∆V = K∆U,

(10)

where K is the coefficients of Eq. (9). The objective of the micropump is to alter the operating voltage between
zero and a positive amount, with the difference in voltage by ∆U . Next, the insulin infusion rate is obtained
as:
Q = Kf ∆U,
(11)
where f is the operating frequency of the micropump.
4. PSO algorithm
The PSO algorithm is a relatively novel population-based heuristic optimization technique that is based on a
metaphor of social interaction, namely bird flocking. The key advantages of PSO are: 1) the objective function’s
gradient is not required, 2) PSO is more flexible and robust in comparison with traditional optimization methods,
3) PSO ensures the convergence to the optimal solution, and 4) compared to the GA, PSO takes less time for
each function evaluation as it does not use many of the GA operators, like mutation, crossover, and selection
operator.
In PSO, each candidate solution is called a ‘particle’. Each particle in the swarm represents a candidate
solution to the optimization problem, and if the solution is made up of a set of variables, the particle can
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correspondingly be a vector of variables. In PSO, each particle is flown through the multidimensional search
space, adjusting its position in the search space according to its momentum and both individual and global
memories. Therefore, the particle makes use of the best position encountered by itself and that of its neighbors
to position itself toward an optimal solution. The fitness of each particle can be evaluated according to the
objective function of the optimization problem. At each iteration, the velocity of every particle will be calculated
as follows:
vi (t + 1) = ωvi (t) + c1 r1 (Pid − xi (t)) + c2 r2 (Pgd − xi (t)),
(12)
where xi (t) is the current position of the particle, Pid is the best of the solutions that this particle has reached,
and Pgd is one of the best solutions. After calculating the velocity, the new position of each particle can be
worked out:
xi (t + 1) = xi (t) + vi (t + 1).

(13)

The PSO algorithm is repeated using Eqs. (12) and (13), which are updated at each iteration, until the
prespecified number of generations is reached.
Although the standard PSO (SPSO) involves some important advances by providing high-speed convergence in specific problems, it does exhibit some shortages. It is found that SPSO has a poor ability to search
for a fine particle because it lacks a velocity control mechanism. Many approaches have been attempted to
improve the performance of SPSO by variable inertia weight. The inertia weight is critical for the performance
of PSO, which balances the global exploration and local exploitation abilities of the swarm. A big inertia
weight facilitates exploration, but it makes the particle take a long time to converge. Conversely, a small inertia weight makes the particle converge faster, but it sometimes leads to a local optimum. Hence, there are
several PSO algorithms with an adaptive inertia weight, such as LDW-PSO, nonlinearly decreasing weight PSO
(NLDW-PSO), or time varying inertia weight PSO [26]. To choose the most appropriate one, several factors
must be considered depending on the problem in hand. The computational time is a very important factor
in our application and it should not be a big issue for the implementations. Compared with above mentioned
algorithms, LDW-PSO demonstrates its superiority in the computational complexity, success rate, and solution
quality. Hence, the LDW-PSO algorithm is used in this paper. In NLDW-PSO, the inertia weight is adapted
linearly as follows [27]:
ω(t) = ωmin +

itermax − t
.(ωmax − ωmin ),
itermax

(14)

where itermax is the maximal number of iterations, and tis the current number of iterations. As iterations go,
therefore, ω decreases linearly from ωmax to ωmin .
5. The proposed method
5.1. Structure design
The block diagram of the proposed swarm optimization tuned Mamdani fuzzy controller (SOTFC) for the
regulation of plasma glucose in type 1 diabetic patients is shown in Figure 3. The controller is structured with
a Mamdani-type fuzzy architecture with 2 input linguistic variables and 1 output variable. The input linguistic
variables are the error signal (e) and its rate of change ( ė) , and the output linguistic variable is the exogenous
insulin infusion rate (∆ I in ). In fact, the parameter e represents the difference between the measured blood
glucose level and the reference glucose level.
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Figure 3. General scheme of the proposed controller (SOTFC).

The key components of a fuzzy logic controller are the fuzzifier, the inference engine, the rule base, and
the defuzzifier, as shown in Figure 4. The fuzzifier transforms the numeric into fuzzy sets, and so this operation
is called fuzzification. The inference engine is the main component of the fuzzy logic controller, which performs
all of the logic manipulations in a fuzzy controller. The rule base consists of membership functions and control
rules. Finally, the results of the inference process, which is an output represented by a fuzzy set, is transformed
into a numeric value using the defuzzifier, and this operation is called defuzzification. The membership functions
of the fuzzy controller consist of 3 and 5 membership functions for the inputs’ linguistic variables (e and ė)
and the output’s linguistic variable ( ∆I in ), respectively. The general shape of the membership functions are
as follows:
(
)
2
(z − c)
µ(z) = exp
,
(15)
2σ
where the parameter c is the mean and the parameter σ is the variance of each membership function, the
parameter z is the crisp input amount to be fuzzified, and µ(z) is its membership function grade with numerical
value in the interval [0 1].

Rule Base

Input

Fuzzifier

Inference Engine

Output
Defuzzifier

Figure 4. Components of a fuzzy logic controller.

The linguistic meanings of the input and output membership functions are listed in Tables 1 and 2,
respectively. By the definition of the input and output fuzzy sets, a total of 9 IF-THEN rules are defined. These
rules are listed in Table 3.
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In designing the fuzzy controller, using the submin compositional rule of inference, the AND fuzzifier,
and the center of gravity defuzzifier, the crisp output can be defined as
∫

µC (z) . z dz
Z = ∫
,
µC (z) dz
∗

(16)

where ∫ indicates an algebraic integration. The defuzzified amount goes through an output restrictive and then
to an insulin pump.
Table 1. Label of input membership functions.

Label
Meaning

N
Negative

Z
Zero

P
Positive

Table 2. Label of output membership functions.

Label
Meaning

NL
Negative large

NS
Negative medium

Z
Zero

PS
Positive medium

PL
Positive large

Table 3. Fuzzy IF-THEN rules.

de/dt e
N
Z
P

N
NL
NS
Z

Z
NS
Z
PS

P
Z
PS
PL

In the fuzzy inference engine, if the antecedent part is performed by the MIN operator, the output fuzzy
set related to every fuzzy rule Ri will be cut at αi . The overall inference µc (∆Iin ) can be achieved as follows
[28]:
µc (∆Iin ) = µc1 U µc2 ...µc9 ,

(17)

where µci is the inference result derived from rule i . In this paper, the aggregation part is done by the SUM
operator.
It is noticeable that due to the saturation that exists in each actuator, a limiter is added to the output
of the controller. It avoids the wind-up and wind-down effects, which protects the body against the increasing
or decreasing of the insulin injection dose. Hence,
∆Iin = α∆Iin (def uz ∗ (f uz(K1 ∗ e, K2 ∗ ė))),

(18)

where defuz and fuz denote the defuzzification and the fuzzification operations, respectively. K1 , K2 , and
α∆Iin are also the scale gains of the error, the error rate, and the output, respectively. The overall output of
the controller is stated as follows:

Iin ≥ U
 U
Iin (G(t 1)) + ∆Iin (G(t)) U < Iin < L ,
Iin (G(t)) =
(19)

L
Iin ≤ L
where Iin (G(t)) and Iin (G(t−1 )) demonstrate the current and the previous exogenous insulin quantities at
G(t) and G(t− 1 ), respectively. ∆Iin (G(t)) represents an increment or decrement in the insulin injection due
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to the glucose concentration. Finally, U and L are the upper and the lower limitations of the saturation block,
respectively. This means that the proposed fuzzy controller works in the interval [L,U] mU/min and saturates
outside of this range. Insulin is injected into the body by insulin pump through a needle. Due to the thinness
of the insulin pump’s needle there are limitations in the insulin infusion rate. Indeed, the limiter represents the
limitations of the insulin infusion rate. Figures 5 and 6 describe the effect of the limiter, where it can be seen
that the limiter is capable of keeping the insulin infusion rate in a specified range. We can also see that in the
absence of a limiter, wind-up and wind-down effects occur. The wind-down effect will lead to hyperglycemia
and the wind-up effect will lead to hypoglycemia.

Insulin, U/mL

1.5
1
0.5
0
0

500

1000

1500

wind-up effect without limiter
reference model
wind-down effect without limiter
glucose profile with limiter

300
Glucose, mg/dL

wind-up effect without limiter
wind-down effect without limiter
lower limit
upper limit
insulin infusion with limiter

2

200
100
0
0

Time (min)

500

1000

1500

Time (min)

Figure 5. Effect of the limiter in insulin infusion rate.

Figure 6. Effect of the limiter in hyperglycemia and
hypoglycemia.

From Eq. (19), at t = 0, the overall quantity of the insulin can be obtained as:
Iin (G(0)) = ∆Iin (G(0)) + IC.

(20)

Here, the parameter IC is the quantity of injected insulin from the pump at t = 0. This parameter increases the
speed response in the tracking of the reference model. Moreover, the parameter αi , called the matching level
of every fuzzy rule, is computed. For instance, the matching level of rule 1 can be achieved by the following:
α1 = µN (e) ∩ µN (ė),

(21)

where α1 is the matching level of R1 and µN (e) and µN (ė) are the membership function grades of the crisp
inputs ( e) and ( ė), respectively. The symbol ∩ represents the AND operator, which is considered to be the
product operator. In the next section, the implementation of the SOTFC will be illustrated.

5.2. Implementation
As mentioned before, the goal of the SOTFC is to mimic the normal behavior of glucose and insulin as
characterized by the reference model, not to lower the blood glucose level to a specified preset glucose amount as
described in [17–20]. Based on this, LDW-PSO is employed for tuning the parameters of the input and output
membership functions, as defined in Eq. (15), and the weighting parameters, i.e. K1 , K2 , and α∆Ii . To set
the best limit on the exogenous insulin infusion, the parameters U and L are also determined by LDW-PSO.
In addition, to determine the best value of the insulin, injected at the start of the simulation, the parameter IC
is obtained by LDW-PSO.
Before proceeding with the optimization operations, a performance criterion should be defined first.
In general, a heuristic algorithm such as PSO only needs to evaluate the fitness function to guide its search
and there is no requirement for derivatives about the system. In this paper, the absolute percentage error is
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considered. Thus, the fitness function is defined as follows:
1 ∑ GM odel − GF uzzy
,
n t=0
GM odel
n

J=

(22)

where GM odel is the glucose amount obtained by the reference model, GF uzzy represents the real output of
glucose–insulin system (see Figure 3), and n is the duration of simulation.
6. Simulation results
In order to demonstrate the performance of the SOTFC, simulations are carried out in 2 parts: with and
without the uncertainty. To simulate the SOTFC, MATLAB software is applied. The numerical values of the
glucose–insulin model’s parameters are listed in Table 4. Simulation results have been gained for 100 runs of
particles considered during a period of 1440 min (24 h). The parameters of LDW-PSO are also listed in Table 5.
Table 4. The parameters of the glucose–insulin model [21].

Parameters
Vg
Ub
C2
C3
Vp
Vi
ti

Units
1
mg min−1
mg 1−1
mg 1−1
1
1
min

Values
10
72
144
1000
3
11
100

Parameters
U0
Um
B
C4
Rg
α̂
C5

Units
mg min−1
mg min−1
1
mU 1−1
mg min−1
1 mU−1
mU 1−1

Values
40
940
1.77
80
180
0.29
26

Table 5. The parameters of LDW-PSO.

Size of the swarm
Dimension of the problem
Maximum number of iterations
Cognitive parameter C1
Social parameter C2
Construction factor C

50
28
100
1
1
1

6.1. Performance analysis without uncertainty
The goal of the optimization problem is to set the parameters of the control system so that the glucose profile by
the SOTFC is very close to that of the reference model, as shown in Figure 7. As shown in [29], the membership
functions with various averages and constant variances have better performance in mimicking the blood glucose
response of the reference model. Thus, the variance of all Gaussian membership functions is set to 0.3.

Glucose, mg/dL

150

100

50
0

500

Time (min)

1000

1500

Figure 7. Glucose profile of the reference model.
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The average of membership functions with the linguistic variables NL, NS, and N are defined on the
interval [–1 0], whereas the linguistic variables PL, PS, and P are defined on the interval [0 1]. The average of
linguistic variable Z is also on the interval [–0.5 0.5]. Finally, the parameters K1 , K2 , α∆Iin , U , L, and IC

1

E-N
E-Z
E-P

0.5

0

-1

-0.5

0
Error

0.5

1

1

NL
NS
Z
PS
PL

0.5

0
-1

-0.5

0
Controller input

0.5

1

CE-N
CE-Z
CE-P

0.5

0
-1

-0.5

0
Error rate

0.5

1

Figure 9. Obtained membership functions of input 2.

Controller input

Degree of membership

Figure 8. Obtained membership functions of input 1.

Degree of membership

Degree of membership

are defined on the intervals [0 0.5], [0 0.5], [0 0.5], [0.5 2], [0 0.45], and [0 2], respectively. The search space is
considered because of the authors’ knowledge about the problem at hand, such that the optimum values exist
in these intervals. The obtained membership functions of the inputs and the output are shown in Figures 8–10,
respectively. Figure 11 shows the output surface of the controller.

0.1
0
-0.1
1
0

1

-1

Error rate

Figure 10. Obtained membership functions of the output

0
Error

-1

1

Figure 11. Control surface.

(infused insulin).

The difference between the glucose and insulin profile of both the reference model and the SOTFC is
represented in Figures 12 and 13, respectively. Moreover, the closed-loop control parameters obtained by LDWPSO are listed in Table 6. Finally, in order to show the feasibility of the SOTFC, the results are compared with
those obtained in [29], which is summarized below:

Insulin micro U/mL

Glucose, mg/dL

150

100

50
0

Figure 12.

500

Time (min)

1000

1500

Glucose profile with SOTFC (-) and the

reference model (.).

30
25
20
15

0

500

Time (min)

1000

1500

Figure 13. Insulin profile with SOTFC (-) and the reference model (.).

1) The SOTFC in this paper is much less complicated. As shown in Table 3, the designed controller in
this paper has only 9 rules, and with these limited rules, the design requirements are satisfied. In [29], however,
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for achieving satisfactory results, 49 rules were defined.
2) The controller has better performance. As shown in Table 7, the fitness function value is 1.235%, while
in [29], the best obtained value for this parameter was 1.3787%. Moreover, as shown in Table 7, the average
value of the glucose obtained in this paper is 107.4 mg/dL, while the best value of this parameter obtained in
[29] was 106.3488 mg/dL. Moreover, Table 7 shows the lower values of the daily infused insulin compared with
those obtained in [1].
Table 6. The parameters obtained by LDW-PSO.

Parameter
K1
K2
α∆Iin
U (mU/min)
L (mU/min)
IC (mU/min)

Value
0.0358
0.3236
0.3180
1.2012
0.1873
0.1749

Table 7. Comparison of performance analyses.

SOTFC

Controller presented in [29]

Reference model

Fitness function value

1.235 %

1.3787 %

-

Average value of glucose

104.6055 (mg dL –1 min–1)

106.3488 (mg dL –1 min–1)

107.38 (mg dL –1 min–1)

Daily infused insulin

707.595 (mU/min)

708.8412 (mU/min)

705.25 (mU/min)

6.2. Performance analysis with uncertainty
The important part in the design procedure is robustness analysis. In order to demonstrate the robustness of
the SOTFC, 4 general cases are taken into account: 1) uncertainty in the clearance rate parameter, 2) changes
in the glucose intake profile, 3) unusual glucose intake, and 4) error in the measurement of sensor. Moreover,
to illustrate the superiority of the SOTFC, the results in each case are compared with those obtained in [29]. It
is necessary to recall that we consider acceptable plasma glucose to be in the range of 60–140 mg/dL, as stated
in [17].
6.2.1. Uncertainty in the clearance rate parameter
The clearance rate parameter shows the existing difference between patients in terms of insulin absorption. If
this parameter is increased, the insulin degradation rate increases and vice versa. In this part, for simulation
of the existing differences between patients in terms of their insulin absorption, the clearance rate parameter
given in Eq. (2) is considered to be uncertain, whereas its variation dˆi is considered to be up to 20% according
to the following equation:
dˆi = di (1 ± 20%),

(23)

where the nominal value of parameter di is 0.0076. The results are illustrated in Figures 14–17. Using the
upper bound of dˆi , i.e. di (1 + 20%) , the insulin concentration degrades fast. In this condition, the reference
model is unable to preserve the glucose concentration in the allowable range. Consequently, the patients with
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this clearance rate value will face high glucose concentrations. This means that hyperglycemia occurs. This
state happens because the exogenous insulin infusion depends on a time with a preset value (705.24 mU/day).
This value is insufficient to deal with such a situation. Therefore, the insulin concentration of the plasma is very
low, as demonstrated in Figure 15, which leads to an increasing of the blood glucose concentration. Because
of this, more insulin is required for lowering the blood glucose level. In this case, 826.9351 mU/day of insulin
is injected by the insulin infusion pump. However, under the same conditions, 832.3450 mU/day of insulin is
infused by the SOTFC in [29]. This shows the advantage of the SOTFC. It is noticeable that almost 1 h after

180
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25
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Glucose, mg/dL

the start, the blood glucose concentration has reached the interval [73.4844 127.3854] mg/dL, which is in the
acceptable range.
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Figure 15. Insulin profile with SOTFC (-) and the refer-

Insulin micro U/mL
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Figure 17. Insulin profile with SOTFC (-) and the reference model (–) using the lower bound of dˆi .

Using the lower bound of dˆi , i.e. di (1 − 20%), the insulin concentration degrades very slowly. Nearly 1
h after the beginning of the simulation, the insulin concentrations in the reference model and the SOTFC are
[23.0001 31.7970] and [18.2476 26.9122], respectively. It is obvious that the insulin concentration of the reference
model is greater than that of the controller. This occurs because the amount of insulin injected by the controller
(597.8805 mU/day) is less than that injected by the model. However, under similar circumstances, 601.2317
mU/day of insulin was injected by the controller in [29]. This demonstrates the excellence of the SOTFC in
this paper. Therefore, the controller is capable of preserving a blood glucose level within the range of [89.7668
125.1513], which is in the acceptable range, whereas without using the controller, the glucose concentration is
reduced to less than 60 mg/dL at most moments of the simulation. In this case, the patient is faced with a
reduced blood glucose concentration, i.e. hypoglycemia. Referring to Figures 16 and 17, it can be concluded that
the SOTFC is capable of dealing with the existing uncertainties in the parameters of the model and preserving
the glucose concentration in the acceptable range.
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6.2.2. Uncertainty in profile of glucose intake
In this case, it is assumed that the patient eats food 6 times a day and the total time of glucose consumption
is 4 h. These assumptions have been done to verify the performance of the SOTFC in confronting large-sized
meals. The glucose intake profile given in Eq. (3) and demonstrated in Figure 1 is substituted by the new
profile Gin−large given in Eq. (24). Figure 18 depicts this profile. In this case, the glucose value received by
the new glucose profile equals 9 times that of the reference model.

 0.01t2 0 ≤ t < 120 (min)
0.01 + 120 ≤ t ≤ 240 (min)
Gin−large (t) =

(120 − (t − 120))2

(24)

Gin−large is overstated to confirm that the SOTFC can cope appropriately with large extent meals. In addition,
the controller’s ability to deal with other glucose inputs is investigated. Figures 19 and 20 represent the glucose
and the insulin profiles resulting from large glucose input, respectively. An hour and a half after the start of
the simulation, the glucose concentration by the controller reaches the range of [84.6489 122.3334], while in the
absence of the controller, the blood glucose level will be increased to the range of [87.4235 130.5369]. This fact
demonstrates that the SOTFC is able to maintain the blood glucose level within the acceptable range. Due
to the magnitude of the glucose receiving profile, the predetermined amounts of the injected insulin by the
reference model are insufficient, and so greater amounts of insulin are injected by the controller. In this case,
732.6526 mU/day of insulin is injected by the SOTFC. However, under the same conditions, 747.9600 mU/day
of insulin has been infused by the controller in [29]. On the other hand, this shows the ability of the controller
in comparison to the existing controller in [29].

Glucose, mg/dL

Glucose, mg/dL
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5
0
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Time (min)
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Figure 18. The glucose intake profile given in Eq. (24).

140
120
100
80
0

500

Time (min)

1000

1500

Figure 19. Glucose profile when the glucose intake profile
changes. Glucose profile with SOTFC (-) and the reference
model (–).

6.2.3. Unusual glucose intake
In this case, the performance of the SOTFC against an unexpected glucose disturbance is evaluated. The
highest rate of insulin infusion based on the glucose profile demonstrated in Figure 1 is 5 mg dL −1 min −1 . In
order to simulate the real condition, it is assumed that a patient receives an unusual glucose value GDis (t) for
a duration of 5 min within a certain range of the glucose concentration profile, as follows:
{
10 750 ≤ t ≤ 754 (min)
GDis (t) =
.
(25)
0
otherwise
As can be seen from Eq. (25), the value equal to 10 mg dL −1 min −1 is added to the model of the glucose
intake at the time interval between 750 min and 754 min. This amount is double that of the highest glucose
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absorption rate, and the highest rate of total absorbed glucose can approach 15 mg dL −1 min −1 . Figure 21
confirms that the SOTFC has appropriate performance in dealing with an unusual glucose disturbance. Within
the time interval of applying the disturbance, the highest recorded concentration of glucose is 130.9063 mg/dL,
which is inside the acceptable limits.
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Figure 20. Insulin profile when the glucose intake profile

Figure 21.

changes. Insulin profile with SOTFC (-) and the reference

bance at time interval [750 754] min. Glucose profile with

Glucose profile in presence of the distur-

model (–).

SOTFC (-) and the reference model (–).

6.2.4. Sensor noise
In this case, to consider the effect of measurement noise, a white Gaussian noise with mean equal to 0 and
variance equal 0.2 is considered, which is more severe than the conditions shown in [29]. As demonstrated in
Figures 22 and 23, the regulated glucose concentration obtained by the SOTFC is [82.1050 124.7336] mg/dL,
which is in the acceptable range. This indicates that the SOTFC is robust against the noise of the sensor. Based
on the proper performance of the SOTFC, it is very suitable in practical applications such as a miniaturized
insulin pump. It is noticeable that to use this controller in real-life applications, the characteristic of the insulin
pump must be considered carefully.
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Figure 22. Glucose profile in presence of error noise.

Figure 23. Insulin profile (white Gaussian noise). Insulin

Glucose profile with SOTFC (-) and the reference model

profile with SOTFC (-) and the reference model (–).

(–).

7. Summary of the simulation results
To verify the robust performance of the SOTFC, a group of 4 tests is considered, including: 1) uncertainty
in the clearance rate parameter, 2) changes in the glucose intake profile, 3) unusual glucose intake, and (4)
an error in the measurement of the sensor. Uncertainty in the clearance rate parameter leads to states of
hyperglycemia or hypoglycemia. As was shown, the SOTFC can appropriately cope with both states and it
can keep the blood glucose concentration within the normal range. In the second test, the controller’s ability
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against high glucose absorption, which is 9 times greater than normal glucose absorption, is evaluated. As was
demonstrated, the SOTFC is able to preserve the blood glucose level within the acceptable range. In the third
test, for a duration of 5 min, an unusual glucose intake is imposed into the glucose–insulin model. In this test,
the SOTFC has appropriate performance in dealing with an unusual glucose disturbance. In the final test, the
effect of measurement noise is investigated. To this end, the glucose–insulin model was exposed to a white
Gaussian noise. In this case also, the SOTFC is capable of keeping the blood glucose level within the normal
range.
8. Conclusion and future works
In this paper, a complete model of the glucose–insulin regulation system, which is a nonlinear delay differential
model, was used. The purpose of this paper was to follow the patient glucose profiles of a healthy person with
minimum infused insulin. Due to this, a closed-loop control system based on fuzzy logic control for type 1
diabetic patients was proposed. In order to incorporate knowledge about the patient’s treatment, the SOTFC
was designed using a Mamdani-type fuzzy scheme. In the core of the SOTFC, a heuristic algorithm, namely
LDW-PSO, was utilized to optimize the inputs and the output membership function parameters, as well as the
closed-loop weighting parameters. Insensitivity to the typical error in commercial devices and multiple meal
disturbances, accuracy, robustness to the model parameter variations, and an appropriate settling time are the
key aspects of the SOTFC. The simulation results indicated that the SOTFC can successfully tolerate dynamic
uncertainty in the patient model while rapidly rejecting meal disturbances and tracking the glucose reference.
To show the superiority of the SOTFC, the results were also compared with the existing controller shown
in [29], where the same model for glucose insulin was employed. The comparison demonstrated that the SOTFC
is superior to the existing controller in [29] against uncertainties, and it is able to keep the blood glucose level
inside the acceptable range. Moreover, the SOTFC mimics the glucose profile of a healthy person perfectly,
where the lower value of exogenous insulin infusion is used.
The proposed controller is highly appropriate in feasible applications, like the micropump of insulin
infusion, due to its suitable efficiency under different robust tests. The task of the optimal fuzzy controller is
primarily to tune the pump’s insulin infusion rate due to the glucose concentration by adjusting the voltage
applied to the lead PZT film. In fact, the variation of insulin infusion is rated in proportion to the voltage
variation applied to the PZT film. Moreover, based on the different dietary habits of patients and their ages
and weights, the SOTFC can be readily modified subsequently. Due to the superiority of the type-2 fuzzy
controller over the type-1 fuzzy controller in dealing with disturbances and uncertainty, the use of the type-2
fuzzy controller for the insulin pump is recommended in future works.
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